Collaboration announcement

October 15, 2021

The goal of the collaboration is to accelerate cancer discoveries and the translation of these discoveries into potential improvements for cancer detection, monitoring and therapies.

Richard Gilbertson, Director of the Cancer Research UK Cambridge Centre said: “The CRUK Cambridge Centre is very excited by this new phase in our partnership with our neighbours Abcam on the Biomedical Campus.

“Most importantly, this further deepening of our relationship is great news for patients; enabling even closer working with experts at Abcam to invent new diagnostic, monitoring and treatment strategies.

The collaboration is focused on three key areas of cancer research: early detection, precision medicine and immuno-oncology.

Read the full article.

Collaboration announcement
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect